| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000039447 |
| Receipt No. | R000044978 |
| Scientific Title | Study on the depiction of skeletal muscle function of sarcopenia using diffusion tensor imaging |
| Date of disclosure of the study information | 2020/03/01 |
| Last modified on | 2020/02/10 (Ver. 1) |
| Basic information | ||
| Public title | Evaluation of the skeletal muscle function using diffusion tensor imaging | |
| Acronym | Evaluation of the skeletal muscle using diffusion tensor imaging | |
| Scientific Title | Study on the depiction of skeletal muscle function of sarcopenia using diffusion tensor imaging | |
| Scientific Title:Acronym | Evaluation of the skeletal muscle using diffusion tensor imaging | |
| Region |
|
|
| Condition | |||
| Condition | sarcopenia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To establish morphological and functional evaluation of skeletal muscle using diffusion tensor imaging |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The diffusion tensor imaging parameter of skeletal muscle |
| Key secondary outcomes | SARC-F (Questionnaire)
Lower leg circumference Grip power Lower limb muscle strength Physical ability (walking speed,timed-up-and-go test (TUG) , Chair rise test) Balance ability (Functional reach test, Standing on single leg) Body composition |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Evaluation of physical function and body composition, and MRI imaging are performed for the sarcopenia group. | |
| Interventions/Control_2 | Evaluation of physical function and body composition, and MRI imaging are performed for the non-sarcopenia group. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients in hospital or outpatient of hospital of Kyoto Prefectural University of Medicine, or a person who participated in the Uzumasa physical fitness measurement at Kyoto University of Advanced Science
2.Patients who consent to study participation with the document by free will 3.Patients aged 65 and over at the time of consent acquisition 4.Gender does not matter [Sarcopenia group:10 people] 1) The lower leg circumference is below the sarcopenia screening standard value by AWGS (Asian Working Group for Sarcopenia) 2019 cut-off value: male<34cm, female<33cm 2)Those who meet the sarcopenia diagnostic criteria by AWGS 2019 (sarcopenia, severe sarcopenia; A+B, A+C, or A+B+C) A. Low skeletal muscle mass evaluated by Bioelectrical Impedance Analysis cut-off value:male<7.0kg/m2, female<5.7kg/m2 B. Low muscle strength evaluated by grip power cut-off value:male<28kg, female<18kg C. Low physical function evaluated by walking speed cut-off value<1.0m/s [Non-sarcopenia group:10 people] Those who do not meet the above criteria |
|||
| Key exclusion criteria | 1. Pregnant woman
2. Inappropriate MRI imaging for the following reasons Pacemaker user History of cerebral artery clipping Use non-MRI compatiblemetal implants in the body Use of metal implant in lower leg Tattoo and art makeup Claustrophobia 3. Those who have difficulty assessing motor function for the following reasons History of myocardial infarction, symptomatic angina or arrhythmias. Uncontrolled tachycardia Uncontrolled hypertension Symptomatic lung disease High risk of fracture Infectious disese 4. Others. The person whom the doctor judged inappropriate |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medical Science, Kyoto Prefectural University of Medicine | ||||||
| Division name | Department of Rehabilitation Medicine | ||||||
| Zip code | 602-8566 | ||||||
| Address | 465, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto | ||||||
| TEL | 075-251-5324 | ||||||
| reha@koto.kpu-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medical Science, Kyoto Prefectural University of Medicine | ||||||
| Division name | Department of Rehabilitation Medicine | ||||||
| Zip code | 602-8566 | ||||||
| Address | 465, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto | ||||||
| TEL | 075-251-5324 | ||||||
| Homepage URL | |||||||
| reha@koto.kpu-m.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Rehabilitation Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan society for the promotion of science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto Prefectural University of Medicine, Clinical Research Review Board |
| Address | 465, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan |
| Tel | 075-251-5111 |
| rinri@koto.kpu-m.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044978 |